Research Article

[Retracted] Prediction Models for One-Year Survival of Adult Patients with Acute Kidney Injury: A Longitudinal Study Based on the Data from the Medical Information Mart for Intensive Care III Database

Table 2

Comparisons of characteristics in participants who survived or dead with AKI.

VariableTotal (n = 6050)Death group (n = 2525)Survival group (n = 3525)Statistical magnitude

Gender (female), n (%)3333 (55.09)1420 (56.24)1913 (54.27)χ2 = 2.3030.129
Ethnicity, n (%)χ2 = 21.807<0.001
 Asian173 (2.86)97 (3.84)76 (2.16)
 African American605 (10.00)226 (8.95)379 (10.75)
 Hispanic179 (2.96)67 (2.65)112 (3.18)
 Others165 (2.73)63 (2.50)102 (2.89)
 White4928 (81.45)2072 (82.06)2856 (81.02)
Marital status, n (%)χ2 = 68.946<0.001
 Married2887 (47.72)1249 (49.47)1638 (46.47)
 Not married2166 (35.80)771 (30.53)1395 (39.57)
 Widowed997 (16.48)505 (20.00)492 (13.96)
Age, M (Q1, Q3)67.52 (54.33, 79.56)73.56 (60.64, 82.75)63.05 (51.24, 75.87)Z = 19.022<0.001
LOS in hospital, M (Q1, Q3)9.19 (5.47, 16.66)9.00 (5.10, 16.77)9.38 (5.68, 16.63)Z = −1.7410.082
LOS in ICU, M (Q1, Q3)3.91 (2.14, 8.07)4.31 (2.38, 8.76)3.65 (2.02, 7.67)Z = 6.480<0.001
First care unit, n (%)χ2 = 2.2850.809
 CCU812 (13.42)331 (13.11)481 (13.65)
 CSRU1597 (26.40)670 (26.53)927 (26.30)
 MICU2010 (33.22)836 (33.11)1174 (33.30)
 NICU61 (1.01)30 (1.19)31 (0.88)
 SICU883 (14.60)377 (14.93)506 (14.35)
 TSICU687 (11.36)281 (11.13)406 (11.52)
AKI stage 48 hr, n (%)χ2 = 226.572<0.001
 11538 (25.42)511 (20.24)1027 (29.13)
 22880 (47.60)1081 (42.81)1799 (51.04)
 31632 (26.98)933 (36.95)699 (19.83)
Vasopressor (yes), n (%)1264 (20.89)623 (24.67)641 (18.18)χ2 = 37.480<0.001
Congestive heart failure (yes), n (%)2025 (33.47)990 (39.21)1035 (29.36)χ2 = 64.051<0.001
Hypertension (yes), n (%)3377 (55.82)1362 (53.94)2015 (57.16)χ2 = 6.1950.013
CPD (yes), n (%)1396 (23.07)616 (24.40)780 (22.13)χ2 = 4.2650.039
Diabetes uncomplicated (yes), n (%)1334 (22.05)544 (21.54)790 (22.41)χ2 = 0.6430.423
Renal failure (yes), n (%)1202 (19.87)611 (24.20)591 (16.77)χ2 = 51.042<0.001
Liver disease (yes), n (%)1205 (19.92)619 (24.51)586 (16.62)χ2 = 57.429<0.001
AF (yes), n (%)1784 (29.49)940 (37.23)844 (23.94)χ2 = 124.867<0.001
Respiratory disease (yes), n (%)1456 (24.07)704 (27.88)752 (21.33)χ2 = 34.516<0.001
Mechanical ventilation (yes), n (%)5766 (95.31)2367 (93.74)3399 (96.43)χ2 = 23.671<0.001
SBP, mean ± SD120.22 ± 23.42116.52 ± 23.43122.87 ± 23.06t = −10.49<0.001
DBP (mmHg), mean ± SD61.22 ± 15.5558.44 ± 14.8463.21 ± 15.75t = −12.01<0.001
Heart rate, mean ± SD86.90 ± 18.7088.41 ± 19.3185.83 ± 18.17t = 5.27<0.001
Respiratory rate, mean ± SD19.78 ± 6.2320.23 ± 6.3519.46 ± 6.13t = 4.77<0.001
Temperature, mean ± SD36.84 ± 0.8436.74 ± 0.9036.92 ± 0.79t = −8.16<0.001
SpO2%, mean ± SD96.95 ± 3.6496.77 ± 4.3397.07 ± 3.05t = −3.020.003
MAP, mean ± SD78.64 ± 16.6476.02 ± 16.1680.51 ± 16.73t = −10.44<0.001
PT, M (Q1, Q3)13.70 (13.70, 14.90)13.70 (13.70, 15.80)13.70 (13.70, 14.50)Z = 9.140<0.001
WBC, M (Q1, Q3)11.50 (7.90, 16.50)12.30 (8.10, 17.80)11.20 (7.80, 15.80)Z = 5.107<0.001
LYM, M (Q1, Q3)9.00 (5.20, 15.50)8.00 (4.30, 13.80)10.00 (6.00, 16.50)Z = −10.849<0.001
NEUT, mean ± SD78.25 ± 15.4078.20 ± 17.4078.29 ± 13.80t = −0.210.831
PLT, M (Q1, Q3)213.00 (143.00, 292.00)202.00 (122.00, 290.00)219.00 (156.00, 294.00)Z = −6.454<0.001
Hemoglobin, mean ± SD11.25 ± 2.3410.76 ± 2.2611.61 ± 2.34t = −14.10<0.001
RDW, mean ± SD15.46 ± 2.3216.25 ± 2.5114.89 ± 2.00t = 22.68<0.001
Hematocrit, mean ± SD33.61 ± 6.7932.45 ± 6.6634.45 ± 6.76t = −11.44<0.001
Albumin, mean ± SD3.11 ± 0.722.91 ± 0.693.25 ± 0.70t = −18.55<0.001
Creatinine, M (Q1, Q3)1.20 (0.80, 2.00)1.40 (0.90, 2.40)1.10 (0.80, 1.70)Z = 11.533<0.001
INR, M (Q1, Q3)1.30 (1.10, 1.70)1.40 (1.20, 1.90)1.28 (1.10, 1.50)Z = 16.021<0.001
BUN, M (Q1, Q3)25.00 (16.00, 43.00)32.00 (20.00, 52.00)22.00 (14.00, 35.00)Z = 19.745<0.001
Glucose, M (Q1, Q3)134.00 (106.00, 173.00)131.00 (104.00, 171.00)135.00 (108.00, 175.00)Z = −3.2170.001
Bicarbonate, mean ± SD22.73 ± 5.4422.32 ± 5.7923.02 ± 5.16t = −4.80<0.001
Sodium, mean ± SD138.31 ± 5.80138.10 ± 6.29138.46 ± 5.42t = −2.290.022
Potassium, mean ± SD4.30 ± 0.914.39 ± 0.954.24 ± 0.87t = 6.26<0.001
Chloride, mean ± SD104.93 ± 6.84104.81 ± 7.33105.01 ± 6.46t = −1.130.259
Calcium, mean ± SD8.24 ± 1.058.17 ± 1.018.29 ± 1.06t = −4.57<0.001
Anion gap, mean ± SD16.10 ± 4.8816.53 ± 4.8815.79 ± 4.85t = 5.89<0.001
Bilirubin, M (Q1, Q3)0.70 (0.40, 1.40)0.80 (0.50, 2.00)0.68 (0.40, 1.20)Z = 9.070<0.001
NLR, M (Q1, Q3)8.94 (4.79, 16.20)10.20 (5.33, 19.50)8.14 (4.48, 14.38)Z = 9.372<0.001
PLR, M (Q1, Q3)203.04 (117.50, 353.48)219.12 (119.67, 398.35)193.97 (116.42, 323.27)Z = 4.531<0.001
NPAR, M (Q1, Q3)25.70 (21.22, 31.11)27.50 (22.82, 33.78)24.41 (20.43, 29.17)Z = 15.374<0.001
PNI, M (Q1, Q3)36.95 (30.93, 43.14)34.31 (28.62, 40.10)38.85 (32.88, 44.93)Z = −18.714<0.001

LOS: length of stay, CSRU: cardiac surgery recovery unit, MICU: medical intensive care unit, NICU: neonatal intensive care unit, SICU: surgical intensive care unit, TSICU: trauma and surgical intensive care unit, COPD: chronic obstructive pulmonary disease, AF: atrial fibrillation, AKI: acute kidney injury, SBP: systolic blood pressure, DBP: diastolic blood pressure, SpO2: peripheral oxygen saturation, MAP: mean arterial pressure, PT: prothrombin time, WBC: white blood cell, LYM: lymphocyte, NEUT: neutrophil, PLT: platelets, RDW: red cell distribution width, INR: international normalized ratio, PNI: prognostic nutritional index, PLR: platelet-to-lymphocyte ratio, NPAR: neutrophil percentage-to-albumin ratio, NLR: neutrophil-to-lymphocyte ratio.